Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
The drug has already been granted priority review, positioning it for a potential regulatory decision by mid 2026
The funding sources had no role in the design of this study nor any role during its execution, analyses, data interpretation, or decision to submit results
Patients were randomized to TRESIBA or insulin detemir once-daily in the evening
2021 Feb 10;384(11):9891002
Differential localization of gamma-aminobutyric acid type A and glycine receptor subunits and gephyrin in the human pons, medulla oblongata and uppermost cervical segment of the spinal cord: an immunohistochemical study
US$ 26.33
US$ 29.20
US$ 25.73
US$ 24.67
